RecruitingNot ApplicableNCT05832567

Mechanisms of Open and Hidden Placebo in Stroke Recovery


Sponsor

Spaulding Rehabilitation Hospital

Enrollment

56 participants

Start Date

Sep 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This trial aims to investigate whether placebo in isolation (open and hidden) has a specific neural signature in stroke subjects thus providing a novel mechanism to explain placebo effects that can be used to ultimately enhance stroke rehabilitation therapies.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Active rTMS, Open Placebo, and others for people with hemiparesis and stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive rTMS

Subjects will undergo repetitive transcranial magnetic stimulation, each session lasting 20 minutes.

DEVICESham rTMS

Subjects will undergo sham repetitive transcranial magnetic stimulation, each session lasting 20 minutes.

DIETARY_SUPPLEMENTOpen Placebo

The open placebo will consist of an inactive substance pill commonly used in clinical trials and given to the subject in a regular pill dispenser.


Locations(1)

Spaulding Hospital Cambridge

Cambridge, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05832567


Related Trials